Functionalized Chitosan Decorated Hafnium Oxide@Gold Core–Shell Nanoparticles for Multimodal Cancer Therapy

Author:

Gupta Aastha1ORCID,Sood Ankur1,Bhardwaj Dimpy1,Shrimali Nishith2,Singhmar Ritu1,Chaturvedi Shubhra3,Guchhait Prasenjit2,Agrawal Garima1ORCID

Affiliation:

1. School of Chemical Sciences and Advanced Materials Research Centre Indian Institute of Technology Mandi Mandi Himachal Pradesh 175075 India

2. Disease Biology Laboratory Regional Centre for Biotechnology National Capital Region Biotech Science Cluster Faridabad Haryana 121001 India

3. Institute of Nuclear Medicine and Allied Sciences (INMAS) Defence Research and Development Organization (DRDO) Lucknow Road, Timarpur New Delhi 110054 India

Abstract

AbstractHerein, the fabrication of chitosan stabilized multifunctional hafnium oxide@gold core–shell nanoparticles (HAT NPs) (≈12 nm) is described. The developed nanoparticulate system offers multimodal action by providing stimuli responsive anticancer drug delivery along with imparting radiosensitization to cancer cells, thereby protecting surrounding normal tissues from damage. HAT NPs exhibit good capability of loading doxorubicin (DOX), an anticancer drug with ≈87% encapsulation efficiency. DOX loaded HAT NPs are able to release ≈91% DOX under GSH reducing conditions, that is a representative of the cancer cell microenvironment. The cytotoxicity of the developed DOX loaded HAT NPs is tested against breast cancer cells (MDA‐MB‐231) showing higher cytotoxicity as compared to free DOX. In addition, the ability of HAT NPs to generate ROS activity upon irradiation by gamma radiations (0.5 & 5 Gy) is also analyzed in cancer cells to demonstrate the ability of synthesized system as a potent candidate to present radio sensitization. Further, in vivo biodistribution studies are executed to understand the tissue specific retention of HAT NPs for their future utility in targeted cancer treatment applications.

Funder

Indian Institute of Technology Mandi

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry (medical),Genetics (clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3